MA54373A - Formulation d'administration de médicament au côlon - Google Patents

Formulation d'administration de médicament au côlon

Info

Publication number: MA54373A
Authority: MA; Morocco
Prior art keywords: drug delivery; delivery formulation; colon drug; colon; formulation
Prior art date: 2018-12-07

Application number

MA054373A

Other languages

English (en)

Inventor

González Roberto Carlos Bravo

Felipe Varum

Original Assignee

Tillotts Pharma Ag

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2018-12-07

Filing date

2019-12-05

Publication date

2022-03-16

2019-12-05 Application filed by Tillotts Pharma Ag filed Critical Tillotts Pharma Ag

2022-03-16 Publication of MA54373A publication Critical patent/MA54373A/fr

Links

210000001072 colon Anatomy 0.000 title 1
238000012377 drug delivery Methods 0.000 title 1
238000009472 formulation Methods 0.000 title 1
239000000203 mixture Substances 0.000 title 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2886—Dragees; Coated pills or tablets, e.g. with film or compression coating having two or more different drug-free coatings; Tablets of the type inert core-drug layer-inactive layer
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/60—Salicylic acid; Derivatives thereof
- A61K31/606—Salicylic acid; Derivatives thereof having amino groups
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/284—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone
- A61K9/2846—Poly(meth)acrylates
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/2853—Organic macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyethylene glycol, polyethylene oxide, poloxamers, poly(lactide-co-glycolide)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2806—Coating materials
- A61K9/2833—Organic macromolecular compounds
- A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
- A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
- A61K9/2893—Tablet coating processes
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Epidemiology (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Organic Chemistry (AREA)
Inorganic Chemistry (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Medicinal Preparation (AREA)

MA054373A 2018-12-07 2019-12-05 Formulation d'administration de médicament au côlon MA54373A (fr)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP18211154.2A EP3662902B1 (fr)	2018-12-07	2018-12-07	Formulation pour la liberation de médicaments dans le côlon

Publications (1)

Publication Number	Publication Date
MA54373A true MA54373A (fr)	2022-03-16

Family

ID=64661235

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
MA054373A MA54373A (fr)	2018-12-07	2019-12-05	Formulation d'administration de médicament au côlon

Country Status (27)

Country	Link
US (1)	US20220016038A1 (fr)
EP (2)	EP3662902B1 (fr)
JP (1)	JP7423630B2 (fr)
KR (1)	KR102777256B1 (fr)
CN (1)	CN113164401A (fr)
AR (1)	AR117682A1 (fr)
AU (1)	AU2019394086B2 (fr)
BR (1)	BR112021010915A2 (fr)
CA (1)	CA3122025A1 (fr)
CL (1)	CL2021001445A1 (fr)
CO (1)	CO2021008688A2 (fr)
CR (1)	CR20210365A (fr)
EA (1)	EA202191574A1 (fr)
ES (1)	ES2994844T3 (fr)
GE (2)	GEP20237517B (fr)
IL (1)	IL283721B2 (fr)
JO (1)	JOP20210135A1 (fr)
MA (1)	MA54373A (fr)
MX (1)	MX2021006693A (fr)
MY (1)	MY210540A (fr)
PH (1)	PH12021551291A1 (fr)
SA (1)	SA521422194B1 (fr)
SG (1)	SG11202105695WA (fr)
TW (1)	TWI827753B (fr)
UA (1)	UA128235C2 (fr)
WO (1)	WO2020115254A1 (fr)
ZA (1)	ZA202103678B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP3662901B1 (fr)	2018-12-07	2025-01-01	Tillotts Pharma AG	Formulation de médicaments à une liberation ralentie avec une couche extérieure comprenant un polymère dégradable par des enzymes, sa composition et son processus de production
EP4382099A1 (fr)	2022-12-05	2024-06-12	ADD Advanced Drug Delivery Technologies, Ltd.	Pastilles à libération modifiée chargées de médicament

Family Cites Families (23)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
GB8812490D0 (en)	1988-05-26	1988-06-29	Agricultural & Food Res	Delayed release formulations
GB8926639D0 (en)	1989-11-24	1990-01-17	Agricultural & Food Res	Delayed release formulations
US5422121A (en)	1990-11-14	1995-06-06	Rohm Gmbh	Oral dosage unit form
US5914132A (en) *	1993-02-26	1999-06-22	The Procter & Gamble Company	Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
US5656290A (en)	1993-02-26	1997-08-12	The Procter & Gamble Company	Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5482718A (en) *	1994-03-23	1996-01-09	Hoffmann-La Roche Inc.	Colon-targeted delivery system
GB9722426D0 (en)	1997-10-23	1997-12-24	Univ London Pharmacy	Controlled release formulations
GB9724186D0 (en)	1997-11-14	1998-01-14	British Tech Group	Low temperature coatings
FI20000780A7 (fi)	2000-04-03	2001-10-04	Novasso Oy	Peroraalinen lääkemuoto lääkeaineen hallituksi vapauttamiseksi
GB2367002A (en)	2000-09-25	2002-03-27	British Sugar Plc	Coating composition
GB0203421D0 (en)	2002-02-13	2002-04-03	Alizyme Therapeutics Ltd	Composition
US7670627B2 (en)	2002-12-09	2010-03-02	Salvona Ip Llc	pH triggered targeted controlled release systems for the delivery of pharmaceutical active ingredients
US9149439B2 (en) *	2005-03-21	2015-10-06	Sandoz Ag	Multi-particulate, modified-release composition
DE102005032806A1 (de)	2005-07-12	2007-01-18	Röhm Gmbh	Verwendung eines teilneutralisierten, anionischen (Meth)acrylat-Copolymers als Überzug für die Herstellung einer Arzneiform mit einer Wirkstofffreisetzung bei erniedrigten pH-Werten
GB0607534D0 (en)	2006-04-13	2006-05-24	Univ London Pharmacy	Colonic drug delivery formulation
DK2152250T3 (da)	2007-05-07	2019-12-09	Evonik Degussa Gmbh	Faste doseringsformer, der omfatter et enterisk overtræk, med accelereret lægemiddelfrigivelse
HRP20192210T1 (hr)	2012-04-30	2020-02-21	Tillotts Pharma Ag	Formulacija lijeka s produženim otpuštanjem
EP3187171B1 (fr) *	2012-04-30	2024-09-25	Tillotts Pharma AG	Formulation de médicament à libération retardée
US10799515B2 (en) *	2013-10-29	2020-10-13	Tillotts Pharma Ag	Delayed release drug formulation
CN105412904A (zh) *	2014-06-17	2016-03-23	深圳翰宇药业股份有限公司	利那洛肽肠溶缓释微丸胶囊制剂及其制备方法和用途
CN105832691B (zh) *	2016-05-31	2018-10-02	深圳市健元医药科技有限公司	一种度拉糖肽结肠定位缓释制剂及其制备方法
CN109562147B (zh) *	2016-06-28	2023-09-01	特里瓦生物制剂有限公司	保护微生物组免受口服抗生素
EP3662900A1 (fr) *	2018-12-07	2020-06-10	Tillotts Pharma AG	Formulation d'administration de médicament colonique

2018
- 2018-12-07 ES ES18211154T patent/ES2994844T3/es active Active
- 2018-12-07 EP EP18211154.2A patent/EP3662902B1/fr active Active
2019
- 2019-12-04 TW TW108144380A patent/TWI827753B/zh active
- 2019-12-05 JO JOP/2021/0135A patent/JOP20210135A1/ar unknown
- 2019-12-05 UA UAA202103910A patent/UA128235C2/uk unknown
- 2019-12-05 GE GEAP201915682A patent/GEP20237517B/en unknown
- 2019-12-05 WO PCT/EP2019/083909 patent/WO2020115254A1/fr not_active Ceased
- 2019-12-05 SG SG11202105695WA patent/SG11202105695WA/en unknown
- 2019-12-05 KR KR1020217020596A patent/KR102777256B1/ko active Active
- 2019-12-05 BR BR112021010915-3A patent/BR112021010915A2/pt unknown
- 2019-12-05 PH PH1/2021/551291A patent/PH12021551291A1/en unknown
- 2019-12-05 JP JP2021532823A patent/JP7423630B2/ja active Active
- 2019-12-05 MX MX2021006693A patent/MX2021006693A/es unknown
- 2019-12-05 EA EA202191574A patent/EA202191574A1/ru unknown
- 2019-12-05 CN CN201980081059.9A patent/CN113164401A/zh active Pending
- 2019-12-05 US US17/309,546 patent/US20220016038A1/en active Pending
- 2019-12-05 MA MA054373A patent/MA54373A/fr unknown
- 2019-12-05 AU AU2019394086A patent/AU2019394086B2/en active Active
- 2019-12-05 MY MYPI2021003029A patent/MY210540A/en unknown
- 2019-12-05 GE GEAP202315682A patent/GEAP202315682A/en unknown
- 2019-12-05 EP EP19816316.4A patent/EP3890709A1/fr active Pending
- 2019-12-05 IL IL283721A patent/IL283721B2/en unknown
- 2019-12-05 CA CA3122025A patent/CA3122025A1/fr active Pending
- 2019-12-05 CR CR20210365A patent/CR20210365A/es unknown
- 2019-12-09 AR ARP190103589A patent/AR117682A1/es unknown
2021
- 2021-05-28 ZA ZA2021/03678A patent/ZA202103678B/en unknown
- 2021-06-02 CL CL2021001445A patent/CL2021001445A1/es unknown
- 2021-06-06 SA SA521422194A patent/SA521422194B1/ar unknown
- 2021-06-30 CO CONC2021/0008688A patent/CO2021008688A2/es unknown

Also Published As

Publication number	Publication date
EP3662902C0 (fr)	2024-07-31
SA521422194B1 (ar)	2023-12-20
GEAP202315682A (en)	2023-02-10
TWI827753B (zh)	2024-01-01
IL283721B2 (en)	2025-08-01
MX2021006693A (es)	2021-09-23
PH12021551291A1 (en)	2022-03-28
UA128235C2 (uk)	2024-05-15
AU2019394086B2 (en)	2025-02-27
CN113164401A (zh)	2021-07-23
ES2994844T3 (en)	2025-02-03
CO2021008688A2 (es)	2021-07-30
JP2022511118A (ja)	2022-01-28
EP3662902B1 (fr)	2024-07-31
IL283721A (en)	2021-07-29
KR20210100664A (ko)	2021-08-17
AR117682A1 (es)	2021-08-25
EP3662902A1 (fr)	2020-06-10
BR112021010915A2 (pt)	2021-08-24
IL283721B1 (en)	2025-04-01
CR20210365A (es)	2021-11-03
EP3890709A1 (fr)	2021-10-13
ZA202103678B (en)	2024-10-30
WO2020115254A1 (fr)	2020-06-11
GEP20237517B (en)	2023-06-26
SG11202105695WA (en)	2021-06-29
JOP20210135A1 (ar)	2023-01-30
CL2021001445A1 (es)	2022-01-21
JP7423630B2 (ja)	2024-01-29
CA3122025A1 (fr)	2020-06-11
US20220016038A1 (en)	2022-01-20
TW202038915A (zh)	2020-11-01
MY210540A (en)	2025-09-30
KR102777256B1 (ko)	2025-03-10
EA202191574A1 (ru)	2021-09-13
AU2019394086A1 (en)	2021-06-17

Publication	Publication Date	Title
MA51617A (fr)	2020-11-25	Mécanisme d'administration de médicament
EP3793680C0 (fr)	2023-11-22	Dispositif d'administration de radio-embolisation
IL291004A (en)	2022-05-01	Drug delivery device
MA50557A (fr)	2020-09-16	Pistons pour dispositifs d'administration de médicament
EP3826589A4 (fr)	2022-04-20	Dispositif ophtalmique pour l'administration de médicaments
MA49949A (fr)	2020-07-01	Mécanisme d'insertion d'aiguille pour dispositif d'administration de médicament
MA50904A (fr)	2020-09-23	Mécanisme d'insertion d'aiguille pour dispositif d'administration de médicament
EP3520843A4 (fr)	2020-04-15	Dispositif d'administration de médicament liquide
EP3621656A4 (fr)	2021-01-27	Formulation pour l'administration d'un médicament pour les yeux
EP3643353A4 (fr)	2021-06-30	Robot d'administration de médicament
EP3829664A4 (fr)	2022-05-04	Pentagalloyl glucose purifié et dispositifs d'administration
EP3967359A4 (fr)	2023-01-25	Dispositif d'administration par iontophorèse
EP3509573A4 (fr)	2020-04-29	Compositions pharmaceutiques pour l'administration d'un peptide
EP3481465A4 (fr)	2020-05-06	Ensemble d'administration de médicament pour médicaments sous forme de cartouches
EP3881883A4 (fr)	2022-01-19	Dispositif d'administration de solution medicamenteuse
EP3600504C0 (fr)	2023-07-12	Dispositif d'administration de médicaments en poudre sèche
EP3925643A4 (fr)	2022-04-20	Appareil d'administration de médicament liquide
EP3661576A4 (fr)	2021-04-28	Nébuliseur médical pour administration rapide de médicament
EP3903745A4 (fr)	2022-02-23	Système d'administration pour implant médical
EP3906017A4 (fr)	2022-12-28	Dispositif d'administration de médicament par voie nasale
DK3914321T3 (da)	2024-11-11	Lægemiddeladministrationsanordning
EP3534987A4 (fr)	2020-04-01	Système d'administration de médicament à dose réglable
EP3801703A4 (fr)	2022-07-27	Système d'administration de médicament intégré dans le tissu
EP3982942A4 (fr)	2023-06-07	Procédés et compositions d'administration de médicament
MA53227A (fr)	2021-11-24	Mécanisme d'activation pour dispositif d'administration de médicament